Dr. Parameswaran Nair is the Frederick E. Hargreave Teva Innovation Chair in Airway Diseases & Professor of Medicine in the Division of Respirology at McMaster University in Hamilton, Ontario, Canada, providing tertiary care to patients with severe asthma and other complex airway and eosinophilic lung diseases. He directs a patient-centred translational research program at the Firestone Institute of St Joseph’s Healthcare, focussed on charactering bronchitis using sputum biomarkers, bio-imaging, and targeted therapy with biologics and small molecule antagonists. His laboratory has contributed to over 300 peer-reviewed publications in high impact general medical, allergy, and respiratory journals (h-index 72), and has been recognized by a Canada Research Chair, Fellowships of the Canadian Academy of Health Sciences, the European Respiratory Society, the American College of Chest Physicians, and Memberships of the National Academy of Medical Sciences of India and Collegium Allergologicum Internationale.